|
Biomarkers, imaging and safety in resmetirom 52 week non-cirrhotic NASH phase 3 clinical trial, completed open-label arm of maestro-NAFLD-1 |
|
|
|
Titel: |
Biomarkers, imaging and safety in resmetirom 52 week non-cirrhotic NASH phase 3 clinical trial, completed open-label arm of maestro-NAFLD-1 |
Auteur: |
Harrison, Dr. S.A. Mangia, Dr. A. Lasierra-Resa, Dr. P. Cubberley, Ms. S. Taub, Dr. R.A. Neff, Dr. G.W. Alkhouri, Dr. Naim Bashir, Dr. Mustafa |
Verschenen in: |
Digestive and liver disease |
Paginering: |
Jaargang 54 () nr. S1 pagina's S48 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|